Histone H3 Lysine 4 Trimethylation, Lysine 27 Trimethylation, and Lysine 27 Acetylation Contribute to the Transcriptional Repression of Solute Carrier Family 47 Member 2 in Renal Cell Carcinoma

被引:12
作者
Yu, Qinqin [1 ]
Liu, Yanqing [1 ]
Zheng, Xiaoli [1 ]
Zhu, Qianying [1 ]
Shen, Zhuowei [1 ]
Wang, Hua [2 ]
He, Huadong [3 ]
Lin, Nengming [3 ]
Jiang, Huidi [1 ]
Yu, Lushan [1 ]
Zeng, Su [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Inst Drug Metab & Pharmaceut Anal, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou, Zhejiang, Peoples R China
[2] Canc Hosp Zhejiang Prov, Dept Urol, Hangzhou, Zhejiang, Peoples R China
[3] Hangzhou First Peoples Hosp, Dept Urol, Hangzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
EMBRYONIC STEM-CELLS; FUNCTIONAL-CHARACTERIZATION; PROGNOSTIC RELEVANCE; GENETIC-VARIANTS; HUMAN MULTIDRUG; METHYLATION; METFORMIN; MATE2-K; CANCER; PHARMACOKINETICS;
D O I
10.1124/dmd.116.073734
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In recent years, finding effective biomarkers for identifying early stage cancer and predicating prognosis is crucial for renal cell carcinoma (RCC) diagnosis and treatment. In this study, a dramatic decrease of the solute carrier family 47 member 2 (SLC47A2) mRNA in RCC comparing with the paired adjacent nontumor tissues from patients at low Tumor Node Metastasis stage was observed. Thus, patients with SLC47A2 transcriptional repression are susceptible to RCC. Little is known about the regulation mechanism of SLC47A2. We found that it was a bivalent gene that was enriched with both histone H3 lysine 4 trimethylation (H3K4me3) and lysine 27 trimethylation (H3K27me3). Loss of mixed lineage leukemia 1 binding at the gene promoter caused decreased H3K4me3 enrichment and H3K4me3/H3K27me3 ratio, and subsequently repressed the expression of SLC47A2. These two epigenetic markers modulated the expression of SLC47A2 simultaneously, suggesting the regulation pattern for bivalent genes. Histone H3 lysine 27 acetylation also contributed to the expression of SLC47A2. An E2F1-histone deacetylase 10 complex catalyzed deacetylation of H3K27, then prevented the enrichment of H3K4me3, and finally reduced SLC47A2 expression. Consequently, the combined effect of all these factors determined SLC47A2 transcriptional repression in RCC tissues.
引用
收藏
页码:109 / 117
页数:9
相关论文
共 50 条
[41]   The genomic landscape of histone modifications in human T cells [J].
Roh, Tae-Young ;
Cuddapah, Suresh ;
Cui, Kairong ;
Zhao, Keji .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (43) :15782-15787
[42]   Methylation of lysine 4 on histone H3: Intricacy of writing and reading a single epigenetic mark [J].
Ruthenburg, Alexander J. ;
Allis, C. David ;
Wysocka, Joanna .
MOLECULAR CELL, 2007, 25 (01) :15-30
[43]   Global Levels of Histone Modifications Predict Prognosis in Different Cancers [J].
Seligson, David B. ;
Horvath, Steve ;
McBrian, Matthew A. ;
Mah, Vei ;
Yu, Hong ;
Tze, Sheila ;
Wang, Qun ;
Chia, David ;
Goodglick, Lee ;
Kurdistani, Siavash K. .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (05) :1619-1628
[44]   Structural Basis for the Requirement of Additional Factors for MLL1 SET Domain Activity and Recognition of Epigenetic Marks [J].
Southall, Stacey M. ;
Wong, Poon-Sheng ;
Odho, Zain ;
Roe, S. Mark ;
Wilson, Jon R. .
MOLECULAR CELL, 2009, 33 (02) :181-191
[45]   The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin [J].
Stocker, S. L. ;
Morrissey, K. M. ;
Yee, S. W. ;
Castro, R. A. ;
Xu, L. ;
Dahlin, A. ;
Ramirez, A. H. ;
Roden, D. M. ;
Wilke, R. A. ;
McCarty, C. A. ;
Davis, R. L. ;
Brett, C. M. ;
Giacomini, K. M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (02) :186-194
[46]  
Tan PH, 2013, AM J SURG PATHOL, V37, P1518, DOI 10.1097/PAS.0b013e318299f12e
[47]   Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H+-organic cation antiporters [J].
Tanihara, Yuko ;
Masuda, Satohiro ;
Sato, Tomoko ;
Katsura, Toshiya ;
Oyawa, Osamu ;
Inui, Ken-ichi .
BIOCHEMICAL PHARMACOLOGY, 2007, 74 (02) :359-371
[48]   Diagnostic and prognostic molecular markers in renal cell carcinoma [J].
Tunuguntla, Hari S. G. R. ;
Jorda, Merce .
JOURNAL OF UROLOGY, 2008, 179 (06) :2096-2102
[49]   Global Analysis of H3K4 Methylation Defines MLL Family Member Targets and Points to a Role for MLL1-Mediated H3K4 Methylation in the Regulation of Transcriptional Initiation by RNA Polymerase II [J].
Wang, Pengfei ;
Lin, Chengqi ;
Smith, Edwin R. ;
Guo, Hong ;
Sanderson, Brian W. ;
Wu, Min ;
Gogol, Madelaine ;
Alexander, Tara ;
Seidel, Christopher ;
Wiedemann, Leanne M. ;
Ge, Kai ;
Krumlauf, Robb ;
Shilatifard, Ali .
MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (22) :6074-6085
[50]   HDAC family: What are the cancer relevant targets? [J].
Witt, Olaf ;
Deubzer, Hedwig E. ;
Milde, Till ;
Oehme, Ina .
CANCER LETTERS, 2009, 277 (01) :8-21